Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Penna

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|April 12, 2016
A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapyMíriam Toledo, Fabio Penna, Francesc Oliva, et al.
Muscle & Nerve|July 18, 2013
Early changes of muscle insulin-like growth factor-1 and myostatin gene expression in gastric cancer patientsAndrea Bonetto, Fabio Penna, Zaira Aversa, et al.
The American Journal of Pathology|February 12, 2013
Autophagic degradation contributes to muscle wasting in cancer cachexiaFabio Penna, Domiziana Costamagna, Fabrizio Pin, et al.
Journal of Molecular Biology|June 1, 2019
Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial FunctionFabio Penna, Riccardo Ballarò, Paula Martinez-Cristobal, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 4, 2018
Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responsesTuuli A Nissinen, Jaakko Hentilä, Fabio Penna, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 14, 2017
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing miceFrancesca Molinari, Fabrizio Pin, Stefania Gorini, et al.
International Journal of Cancer|November 24, 2015
Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonistMíriam Toledo, Sílvia Busquets, Fabio Penna, et al.
Annals of Surgical Oncology|April 27, 2011
Changes in myostatin signaling in non-weight-losing cancer patientsZaira Aversa, Andrea Bonetto, Fabio Penna, et al.
Scientific Reports|July 28, 2016
Autophagy is induced in the skeletal muscle of cachectic cancer patientsZaira Aversa, Fabrizio Pin, Simone Lucia, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 3, 2015
Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signallingJvalini T Dwarkasing, Mark V Boekschoten, Joseph M Argilès, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Journal of Cachexia, Sarcopenia and Muscle|April 12, 2016
A multifactorial anti-cachectic approach for cancer cachexia in a rat model undergoing chemotherapyMíriam Toledo, Fabio Penna, Francesc Oliva, et al.
Muscle & Nerve|July 18, 2013
Early changes of muscle insulin-like growth factor-1 and myostatin gene expression in gastric cancer patientsAndrea Bonetto, Fabio Penna, Zaira Aversa, et al.
The American Journal of Pathology|February 12, 2013
Autophagic degradation contributes to muscle wasting in cancer cachexiaFabio Penna, Domiziana Costamagna, Fabrizio Pin, et al.
Journal of Molecular Biology|June 1, 2019
Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial FunctionFabio Penna, Riccardo Ballarò, Paula Martinez-Cristobal, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 4, 2018
Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responsesTuuli A Nissinen, Jaakko Hentilä, Fabio Penna, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 14, 2017
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing miceFrancesca Molinari, Fabrizio Pin, Stefania Gorini, et al.
International Journal of Cancer|November 24, 2015
Complete reversal of muscle wasting in experimental cancer cachexia: Additive effects of activin type II receptor inhibition and β-2 agonistMíriam Toledo, Sílvia Busquets, Fabio Penna, et al.
Annals of Surgical Oncology|April 27, 2011
Changes in myostatin signaling in non-weight-losing cancer patientsZaira Aversa, Andrea Bonetto, Fabio Penna, et al.
Scientific Reports|July 28, 2016
Autophagy is induced in the skeletal muscle of cachectic cancer patientsZaira Aversa, Fabrizio Pin, Simone Lucia, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 3, 2015
Differences in food intake of tumour-bearing cachectic mice are associated with hypothalamic serotonin signallingJvalini T Dwarkasing, Mark V Boekschoten, Joseph M Argilès, et al.
Pageof 8